The CD8+/Foxp3+ ratio was positively correlated with OS in ESCC patients [29], although the infiltrating Tregs alone is not a good marker for the prediction of survival in ESCC patients [77]. This evidence concerns the gene FOXP3 and esophageal squamous cell carcinoma.